pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • DROSPIRENONE AND ETHINYL ESTRADIOL
    DROSPIRENONE AND ETHINYL ESTRADIOL
    no indication GLENMARK PHARMS LTD
  • Phase 2
    DS-01
    DS-01
    Irritable Bowel Syndrome Seed Health Inc
  • Phase 1
    DS-1103
    Human Epidermal Growth Factor Receptor 2 Low Breast Cance… Integral Molecular Inc
  • Phase 1
← prev
page 86 of 271
next →
Pain89
Neurology1
DS-2243
Solid Tumor
Daiichi Sankyo Co Ltd
  • Phase 2
    DS-3939
    Solid Tumor Daiichi Sankyo Co Ltd
  • Phase 1
    DS-5361
    Head And Neck Squamous Cell Carcinoma (HNSC) Daiichi Sankyo Co Ltd
  • Phase 2
    DS-7011
    Cutaneous Lupus Erythematosus Daiichi Sankyo Co Ltd
  • Phase 1
    DS-9051
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Daiichi Sankyo Co Ltd
  • Phase 2
    DSG3-CAART
    Pemphigus Vulgaris$CABA Cabaletta Bio, Inc.
  • Phase 1
    DSP-0038
    Alzheimer's Disease Sumitomo Pharma America Inc
  • Phase 2
    DSP-107
    Colorectal Cancer KAHR medical Ltd
  • Phase 1
    DSP-2342
    Unspecified Psychiatric Disorders Sumitomo Pharma America Inc
  • Phase 2
    DSP-3077
    Retinitis Pigmentosa (Retinitis) Sumitomo Pharma Co Ltd
  • Phase 1
    DSP-3456
    Treatment Resistant Depression Sumitomo Pharma Co Ltd
  • Phase 1
    DST-2105
    Keratoconjunctivitis Sicca (Dry Eye) DelSiTech Ltd
  • Preclinical
    DT-003
    Open-Angle Glaucoma Diorasis Therapeutics
  • Phase 2
    DT-101
    Major Depressive Disorder Draig Therapeutics Ltd
  • Phase 2
    DT-168
    Fuchs Endothelial Corneal Dystrophy (FECD)$DSGN Design Therapeutics, Inc.
  • Preclinical
    DTI-117
    Urinary Retention Dignify Therapeutics LLC
  • Preclinical
    DTI-301
    Constipation Dignify Therapeutics LLC
  • Preclinical
    DUET-101
    Bladder Cancer Duet Therapeutics Inc
  • DULOXETINE
    DULOXETINE
    no indication INVENTIA
  • DULOXETINE HYDROCHLORIDE
    DULOXETINE HYDROCHLORIDE
    no indication Alembic Pharmaceuticals Inc
  • DUOPA
    DUOPA (CARBIDOPA)
    1 INDICATIONS AND USAGE DUOPA ® is indicated for the trea…$ABBV AbbVie Inc.
  • DUPIXENT
    DUPIXENT (DUPILUMAB)
    1 INDICATIONS AND USAGE DUPIXENT is an interleukin-4 rece…$REGN REGENERON PHARMACEUTICALS, INC.
  • DURAMORPH PF
    DURAMORPH PF (MORPHINE SULFATE)
    no indication Hikma Pharmaceuticals Plc
  • DUREZOL
    DUREZOL (DIFLUPREDNATE)
    no indication Sandoz Inc
  • DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
    DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
    no indication AUROBINDO PHARMA
  • Phase 1
    DVX-201
    Myelodysplastic Syndrome (Preleukemia)$COEP Coeptis Therapeutics Holdings, Inc.
  • Phase 2
    DX-126262
    Gastric Cancer Hangzhou DAC Biotech Co Ltd